Don't Just Read the News, Understand It.
Get Started
SubscribeLogin
BRICS
Floods
Natural Disasters
Social Media
Artificial Intelligence
Cricket
World Cup
Stock Markets
Tennis
Israel-Hamas Conflict
NBA
Instagram
Telix image

News from Telix

If you want to know if Telix is credible or reliable, look no further. We rank Telix as Unknown factuality. Find out more about our methodology here.

Information about Telix

Where is Telix located?Telix's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Telix News

FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy
United States · United States

FDA Grants Expanded Approval for Illuccix in Patient Selection for Pre-Taxane Radioligand Therapy

The additional indication for the preparation kit of gallium Ga-68 gozetotide may facilitate earlier use of PSMA-targeted treatment for men with prostate cancer.See the Story
Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved in Belgium
Health Care · Belgium

Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved in Belgium

Open the article to view the coverage from TelixRead Article
Telix Manufacturing Solutions Belgium Delivers First GMP-Grade Commercial Doses
Charleroi · Charleroi

Telix Manufacturing Solutions Belgium Delivers First GMP-Grade Commercial Doses

Telix Manufacturing Solutions Belgium Delivers First GMP-Grade Commercial Doses Melbourne (Australia) and Indianapolis (U.S.) | 25 June 2025 Telix today announces that its Telix Manufacturing Solutions (TMS) facility in Brussels South (Seneffe), Belgium, has produced its first Good Manufacturing Practice (GMP)-grade commercial radiopharmaceutical doses and delivered them to the AIRC [1] hospital collaboration in Charleroi, Belgium. TMS Brusse…Read Article

Telix Precision Medicine Announces AlFluor™ Radiochemistry Platform

Telix Precision Medicine Announces AlFluor Radiochemistry Platform Melbourne (Australia) and Indianapolis (U.S.) | 20 June 2025 Telix today announces it has launched a novel PET[1] radiochemistry solution based on 18F-aluminium fluoride (AlF), named AlFluor. The AlFluor platform technology enables flexible radiolabeling of PSMA[2] with either AlF or gallium-68 (68Ga). It also has the potential to be used with ligands targeting NETs[3] and FAP…Melbourne, Australia · MelbourneRead Article

Telix Theranostic Programs and Satellite Symposia on Innovation in PSMA and CAIX Imaging ...

Coverage: 4 sources
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces five abstract presentations and two satellite symposia featuring its developmental theranostic programs and commercial products at the Society…Melbourne, Australia · MelbourneSee the Story

PSMA-PET Imaging Product, Gozellix, Launches on US Market

Gozellix was approved by the FDA in March 2025.United States · United StatesSee the Story

Telix's Illuccix® PSMA-PET Imaging Agent Approved in Germany

MELBOURNE, Australia, June 5, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] imaging agent, Illuccix® (kit for the preparation of gallium-68 gozetotide injection), has been granted marketing authorization…Portugal · PortugalSee the Story

Telix Manufacturing Solutions (TMS) Established in Yokohama, Japan

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and KYOTO, Japan, June 4, 2025 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that it has established Telix Manufacturing Solutions (TMS) in Yokohama, Japan. Telix’s first cyclotron facility in the Asia Pacifi…Yokohama, Japan · YokohamaSee the Story

ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa

Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.Maryland · MarylandSee the Story

Telix to Host Investor Day in New York City on June 11, 2025

Melbourne (Australia) and Indianapolis, IN (U.S.) | 22 May 2025 Telix today announces it will host an Investor Day on Wednesday, June 11, 2025, in person, in New York City, from 8:30am to 12.30pm ET. Institutional investors, analysts and company guests are cordially invited to attend the session, which will focus on the growth opportunities across Telix’s commercial and clinical portfolio of precision medicine and therapeutic radiopharmaceutic…New York State · New YorkRead Article

Telix at ANZSNM Annual Scientific Meeting 2025

MELBOURNE, Australia, May 20, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces a strong presence at the 55th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM ASM 2025), to be held in Melbourne, Australia from 23–25 May 2025. Telix will feature prominently in the scientific program with eight oral and three poster presentations highlig…Melbourne, Australia · MelbourneSee the Story

Breaking News Topics Related to Telix

Melbourne, Australia icon

Melbourne, Australia

Australia icon

Australia

United States icon

United States

Victoria, Australia icon

Victoria, Australia

News
For You
SearchBlindspotLocal